Keryx Bio (KERX) Says Taxpayer Relief Act Delays Oral Only ESRD Drugs
Go back to Keryx Bio (KERX) Says Taxpayer Relief Act Delays Oral Only ESRD Drugs| Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) | Delayed: 3.36 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.36 | 52 Week High | $7.80 | |||
| Open | $438.10 | 52 Week Low | $2.80 | |||
| Day High | $3.36 | P/E | N/A | |||
| Day Low | $3.36 | EPS | $-0.45 | |||
| Volume | 1,132,646 | |||||
